Investigational Drug Information for Molidustat
✉ Email this page to a colleague
What is the development status for investigational drug Molidustat?
Molidustat is an investigational drug.
There have been 10 clinical trials for Molidustat.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 22nd 2018.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are twelve US patents protecting this investigational drug and two hundred and eighty-three international patents.
Summary for Molidustat
US Patents | 12 |
International Patents | 283 |
US Patent Applications | 45 |
WIPO Patent Applications | 50 |
Japanese Patent Applications | 5 |
Clinical Trial Progress | Phase 3 (2018-02-22) |
Vendors | 48 |
Recent Clinical Trials for Molidustat
Title | Sponsor | Phase |
---|---|---|
Maintenance Treatment of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects | Bayer | Phase 3 |
A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
Clinical Trial Summary for Molidustat
Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat
US Patents for Molidustat
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Molidustat | ⤷ Sign Up | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Sign Up |
Molidustat | ⤷ Sign Up | Method for the preparation of triazole compounds | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Sign Up |
Molidustat | ⤷ Sign Up | Amide-substituted phenyltriazole derivatives and uses thereof | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Sign Up |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Molidustat
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Molidustat | Australia | AU2017261372 | 2036-05-05 | ⤷ Sign Up |
Molidustat | Canada | CA3023278 | 2036-05-05 | ⤷ Sign Up |
Molidustat | China | CN107847398 | 2036-05-05 | ⤷ Sign Up |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |